Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

被引：3

作者：

Suiter, Tobias M. ^{[1
]}

Mannucci, Pier Mannuccio ^{[2
,3
]}

Kempton, Christine L. ^{[4
,5
]}

Laffan, Michael ^{[6
]}

Romond, Edward H. ^{[7
]}

Shapiro, Amy D. ^{[8
]}

Birschmann, Ingvild ^{[9
]}

Ragni, Margaret V. ^{[10
,11
]}

Gill, Joan Cox ^{[12
]}

Yee, Thynn Thynn ^{[13
,14
]}

Klamroth, Robert ^{[15
]}

Horling, Frank M. ^{[16
]}

Reipert, Birgit M. ^{[1
]}

Turecek, Peter L. ^{[1
]}

Varadi, Katalin ^{[1
]}

Chapman, Miranda ^{[1
]}

Engl, Werner ^{[1
]}

Wong, Wing Yen ^{[17
]}

Ewenstein, Bruce M. ^{[17
]}

机构：

[1] Baxter Innovat GmbH, Vienna, Austria

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Dept Internal Med & Med Specialties, Milan, Italy

[3] Fdn Milano, Sci Direct, Milan, Italy

[4] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[5] Emory Univ, Sch Med, Dept Hematol Oncol, Atlanta, GA USA

[6] Imperial Coll Sch Med, Hammersmith Hosp, Dept Hematol, London, England

[7] Univ Kentucky, Hemophilia Treatment Ctr, Lexington, KY USA

[8] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA

[9] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany

[10] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA USA

[11] Hemophilia Ctr Western Penn, Pittsburgh, PA USA

[12] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[13] Royal Free Hosp, Haemophilia Ctr, London NW3 2QG, England

[14] Royal Free Hosp, Thrombosis Unit, London NW3 2QG, England

[15] Vivantes Klinikum Friedrichshain, Klini Innere Med Angiol & Haemostaseol, Berlin, Germany

[16] Baxter BioSci, Immunol, Vienna, Austria

[17] Baxter Healthcare Corp, Westlake Village, CA USA

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

10.1182/blood.V118.21.2275.2275

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：987 / 988

页数：2

共 50 条

[41] Quantitative trait loci (QTL) for von Willebrand factor (VWF) levels in a large pedigree with von Willebrand disease (VWD)
Di Paola, J.
Abbott, D.
Wang, K.
Hinckley, J.
Murray, J.
Nixon, B.
Burns, T. L.
Shapiro, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 842 - 842
[42] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
Batlle, Javier
Fernanda Lopez-Fernandez, Maria
Loures Fraga, Esther
Rodriguez Trillo, Angela
Almudena Perez-Rodriguez, Maria
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
[43] INTERPLAY OF VON-WILLEBRAND-FACTOR (VWF) MUTATIONS ON GPIB-BINDING AND F-VIII-BINDING VARIANTS OF VON-WILLEBRAND DISEASE (VWD)
ROCK, AL
KRONER, PA
FAHS, S
KLUESSENDORF, M
FRIEDMAN, KD
MONTGOMERY, RR
BLOOD, 1993, 82 (10) : A339 - A339
[44] Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease
Atiq, Ferdows
Meijer, Karina
Eikenboom, Jeroen
Fijnvandraat, Karin
Mauser-Bunschoten, Eveline P.
van Galen, Karin P. M.
Nijziel, Marten R.
Ypma, Paula F.
de Meris, Joke
Laros-van Gorkom, Britta A. P.
van der Bom, Johanna G.
de Maat, Moniek P.
Cnossen, Marjon H.
Leebeek, Frank W. G.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 93 - 105
[45] Von Willebrand Factor and von Willebrand disease: new approaches to diagnosis
Ines Woods, Adriana
Noemi Blanco, Alicia
Catalina Kempfer, Ana
Paiva, Juvenal
Ines Bermejo, Emilse
Sanchez Luceros, Analia
Angela Lazzari, Maria
ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (02): : 273 - 289
[46] von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
Sanders, Yvonne V.
Groeneveld, Dafna
Meijer, Karina
Fijnvandraat, Karin
Cnossen, Marjon H.
van der Bom, Johanna G.
Coppens, M.
de Meris, Joke
Laros-van Gorkom, Britta A. P.
Mauser-Bunschoten, Eveline P.
Leebeek, Frank W. G.
Eikenboom, Jeroen
BLOOD, 2015, 125 (19) : 3006 - 3013
[47] von Willebrand factor alloantibodies in type 3 von Willebrand disease
Kotnik, Barbara Faganel
Strandberg, Karin
Debeljak, Marusa
Kitanovski, Lidija
Jazbec, Janez
Benedik-Dolnicar, Majda
Bakija, Alenka Trampus
BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
[48] Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease
Mojiri, Anahita
Alavi, Parnian
Jahroudi, Nadia
MICROCIRCULATION, 2019, 26 (04)
[49] In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
Colling, Meaghan E.
Friedman, Kenneth D.
Dzik, Walter H.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
[50] Densitometry of von Willebrand factor (VWF) multimers improves subtyping in type 2 von Willebrand disease (VWD) and quality control of factor VIII/VWF concentrates
Studt, JD
Budde, U
Schneppenheim, R
Prondzinski, MV
Ganser, A
Barthels, M
THROMBOSIS AND HAEMOSTASIS, 1999, : 305 - 305

← 1 2 3 4 5 →